- Home
- FRSX vs CYCC Comparison
FRSX vs CYCC Comparison
Compare FRSX & CYCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRSX
- CYCC
- Stock Information
- Founded
- FRSX N/A
- CYCC 1992
- Country
- FRSX Israel
- CYCC Malaysia
- Employees
- FRSX N/A
- CYCC N/A
- Industry
- FRSX Computer Software: Prepackaged Software
- CYCC Biotechnology: Pharmaceutical Preparations
- Sector
- FRSX Technology
- CYCC Health Care
- Exchange
- FRSX Nasdaq
- CYCC Nasdaq
- Market Cap
- FRSX 9.0M
- CYCC 7.8M
- IPO Year
- FRSX 2017
- CYCC N/A
- Fundamental
- Price
- FRSX $0.50
- CYCC $3.75
- Analyst Decision
- FRSX
- CYCC
- Analyst Count
- FRSX 0
- CYCC 0
- Target Price
- FRSX N/A
- CYCC N/A
- AVG Volume (30 Days)
- FRSX 480.7K
- CYCC 465.6K
- Earning Date
- FRSX 08-08-2025
- CYCC 08-13-2025
- Dividend Yield
- FRSX N/A
- CYCC N/A
- EPS Growth
- FRSX N/A
- CYCC N/A
- EPS
- FRSX N/A
- CYCC N/A
- Revenue
- FRSX $436,000.00
- CYCC $14,000.00
- Revenue This Year
- FRSX N/A
- CYCC $137.21
- Revenue Next Year
- FRSX N/A
- CYCC N/A
- P/E Ratio
- FRSX N/A
- CYCC N/A
- Revenue Growth
- FRSX N/A
- CYCC N/A
- 52 Week Low
- FRSX $0.45
- CYCC $3.08
- 52 Week High
- FRSX $2.63
- CYCC $597.60
- Technical
- Relative Strength Index (RSI)
- FRSX 45.18
- CYCC 28.20
- Support Level
- FRSX $0.45
- CYCC $3.17
- Resistance Level
- FRSX $0.54
- CYCC $3.97
- Average True Range (ATR)
- FRSX 0.05
- CYCC 0.59
- MACD
- FRSX 0.01
- CYCC 1.36
- Stochastic Oscillator
- FRSX 35.50
- CYCC 36.48
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.